KPMA criticized for lukewarm attitude

The Korea Pharmaceutical Manufacturers Association (KPMA) needs to take a bold action against the current drug-pricing system, critics say.

They argued the KPMA’s tepid position on the current issue is derived from its less power for united action.

So far, most members of the association demanded the KPMA’s countermeasure to cope with the cash reward plan, with some referring to it as the...